Your browser doesn't support javascript.
loading
De Novo Autoimmune Hepatitis after COVID-19 Infection in an Unvaccinated Patient.
Durazo, Francisco A; Kristbaum, Kelly; Miller, James; Saeian, Kia; Selim, Motaz; Hong, Johnny C.
Affiliation
  • Durazo FA; Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Kristbaum K; Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Miller J; Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Saeian K; Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Selim M; Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hong JC; Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
Case Reports Hepatol ; 2022: 8409269, 2022.
Article in En | MEDLINE | ID: mdl-36590671
ABSTRACT
Liver test abnormalities have been described during severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection causing coronavirus disease 2019. Most of them consist of elevation of the aminotransferases that resolve once the infection subsides. There are several reports of autoimmune hepatitis developing after vaccination against COVID-19 and one case of autoimmune hepatitis following COVID-19 infection. We present a patient that was not vaccinated against COVID-19 and developed resistant de novo autoimmune hepatitis following COVID-19 infection requiring aggressive immunosuppression.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Case Reports Hepatol Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Case Reports Hepatol Year: 2022 Document type: Article Affiliation country: United States